NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression

Biochemical and Biophysical Research Communications

Volumn 326, Issue 1, 2004, Pages 93-99

  Nath, Niharika ^a   Labaze, Georges ^a   Rigas, Basil ^b   Kashfi, Khosrow ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Catenin; Aspirin; Cancer; Caspases; Chemoprevention; Leukemia; NO donating aspirin

Indexed keywords

2 [(ACETYLOXY)BENZOIC ACID 2 (NITROOXYMETHYL)PHENYL ESTER]; 2 [(ACETYLOXY)BENZOIC ACID 3 (NITROOXYMETHYL)PHENYL ESTER]; 2 [(ACETYLOXY)BENZOIC ACID 4 (NITROOXYMETHYL)PHENYL ESTER]; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA CATENIN; CASPASE 3; NCX 4040; NCX 4060; NITRIC OXIDE DONOR; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; LEUKEMIA; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; ASPIRIN; BETA CATENIN; CASPASES; CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; NITRIC OXIDE DONORS; TRANS-ACTIVATORS;

EID: 9644282960     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.11.009     Document Type: Article

References (19)

1. E.J. Chung, S.G. Hwang, P. Nguyen, S. Lee, J.S. Kim, J.W. Kim, P.A. Henkart, D.P. Bottaro, L. Soon, P. Bonvini, S.J. Lee, J.E. Karp, H.J. Oh, J.S. Rubin, and J.B. Trepel Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin Blood 100 2002 982 990
2. D. Lu, Y. Zhao, R. Tawatao, H.B. Cottam, M. Sen, L.M. Leoni, T.J. Kipps, M. Corr, and D.A. Carson Activation of the Wnt signaling pathway in chronic lymphocytic leukemia Proc. Natl. Acad. Sci. USA 101 2004 3118 3123
3. W.J. Nelson, and R. Nusse Convergence of Wnt, β-catenin and cadherin pathways Science 303 2004 1483 1487
4. R.T. Moon, B. Bowerman, M. Boutros, and N. Perrimon The promise and perils of Wnt signaling through β-catenin Science 296 2002 1644 1646
5. J. Tsutsui, M. Moriyama, N. Arima, H. Ohtsubo, H. Tanaka, and M. Ozawa Expression of cadherin-catenin complexes in human leukemia cell lines J. Biochem. (Tokyo) 120 1996 1034 1039
6. K. Kashfi, Y. Ryyan, L.L. Qiao, J.L. Williams, J. Chen, P. Del Soldato, F. Traganos, and B. Rigas Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect J. Pharmacol. Exp. Ther. 303 2002 1273 1282
7. J.L. Burgaud, E. Ongini, and P. Del Soldato Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents Ann. N. Y. Acad. Sci. 962 2002 360 371
8. B. Rigas, and K. Kashfi Nitric-oxide-donating NSAIDs as agents for cancer prevention Trends Mol. Med. 10 2004 324 330
9. A.W. Bak, W. McKnight, P. Li, P. Del Soldato, A. Calignano, G. Cirino, and J.L. Wallace Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma Life Sci. 62 1998 367 373
10. J.L. Williams, K. Kashfi, N. Ouyang, P. del Soldato, L. Kopelovich, and B. Rigas NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice Biochem. Biophys. Res. Commun. 313 2004 784 788
11. J.L. Williams, S. Borgo, I. Hasan, E. Castillo, F. Traganos, and B. Rigas Nitric oxide-releasing nonsteroidal anti-inflammatory drugs (NSAIDs) alter the kinetics of human colon cancer chemoprevention Cancer Res. 61 2001 3285 3289
12. N. Nath, K. Kashfi, J. Chen, and B. Rigas Nitric oxide-donating aspirin inhibits β-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear β-catenin-TCF association Proc. Natl. Acad. Sci. USA 100 2003 12584 12589
13. J.L. Williams, N. Nath, J. Chen, T.R. Hundley, J. Gao, L. Kopelovich, K. Kashfi, and B. Rigas Growth inhibition of human colon cancer cells by NO-donating aspirin is associated with COX-2 induction and β-catenin/TCF signaling, NF-kappaB and NOS2 inhibition: implications for chemoprevention Cancer Res. 63 2003 7613 7618
14. R.K. Yeh, J. Chen, J.L. Williams, M. Baluch, T.R. Hundley, R.E. Rosenbaum, S. Kalala, F. Traganos, F. Benardini, P. del Soldato, B. Rigas, and K. Kashfi NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property? Biochem. Pharmacol. 67 2004 2197 2205
15. C. Lavagna, P. Del Soldato, J.L. Burgaud, and P. Rampal Nitric oxide-releasing non steroidal anti-inflammatory drugs: a new generation of anti-tumoral molecules Curr. Cancer Drug Targets 3 2003 407 426
16. J.S. Royle, J.A. Ross, I. Ansell, P. Bollina, D.N. Tulloch, and F.K. Habib Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3 J. Urol. 172 2004 338 344
17. A.S. Jaiswal, B.P. Marlow, N. Gupta, and S. Narayan Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 21 2002 8414 8427
18. X.M. Zhou, B.C. Wong, X.M. Fan, H.B. Zhang, M.C. Lin, H.F. Kung, D.M. Fan, and S.K. Lam Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak Carcinogenesis 22 2001 1393 1397
19. Z. Han, P. Pantazis, J.H. Wyche, N. Kouttab, V.J. Kidd, and E.A. Hendrickson A Fas-associated death domain protein-dependent mechanism mediates the apoptotic action of non-steroidal anti-inflammatory drugs in the human leukemic Jurkat cell line J. Biol. Chem. 276 2001 38748 38754